Trial intelligence / Profile preview

Tranexamic acid vs placebo to reduce blood loss in total hip replacement surgery

2010-021497-11Phase 3Active

Sponsor
FRANCISCO BORJA BARRACHINA LARRAZA
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in None comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Total intraoperative and postoperative blood loss and Intraoperative blood loss. Started Sep 2010; status: active.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on 2010-021497-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021497-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call